. miPS cells (5 × 10 5 per mouse) treated with 0.2% DMSO or 50 μM DFX were implanted subcutaneously into the right flank, and tumorigenicity was evaluated. There were no significant differences between groups. Data are represented as average ± S.E.M. (n = 5). Figure S2 . HSC-2 cells (3 × 10 6 per mouse) were injected subcutaneously into the right flank of 24 mice. On day 2 when the tumors reached 150~200 mm 3 , mice were randomly assigned to one of four groups (n = 6 per group), and the treatments were initiated as indicated. The mean body weight of each group ± S.E.M. for comparison between groups are shown. There were no significant differences between groups.
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